Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis - Sanyal, A J; Ratziu, V; Loomba, R (J Hepatol, 2023)